Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1161862
Max Phase: Preclinical
Molecular Formula: C15H24N5O17P3
Molecular Weight: 639.30
Molecule Type: Small molecule
Associated Items:
ID: ALA1161862
Max Phase: Preclinical
Molecular Formula: C15H24N5O17P3
Molecular Weight: 639.30
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 2'-Monophosphoadenosine 5'-Diphosphoribose
Synonyms from Alternative Forms(1):
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OCC2OC(O)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1OP(=O)(O)O
Standard InChI: InChI=1S/C15H24N5O17P3/c16-12-7-13(18-3-17-12)20(4-19-7)14-11(36-38(25,26)27)9(22)6(34-14)2-33-40(30,31)37-39(28,29)32-1-5-8(21)10(23)15(24)35-5/h3-6,8-11,14-15,21-24H,1-2H2,(H,28,29)(H,30,31)(H2,16,17,18)(H2,25,26,27)/t5?,6-,8-,9-,10-,11-,14-,15?/m1/s1
Standard InChI Key: ICNHOLCERMYLRZ-LVEUGINISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 639.30 | Molecular Weight (Monoisotopic): 639.0380 | AlogP: -3.17 | #Rotatable Bonds: 11 |
Polar Surface Area: 338.05 | Molecular Species: ACID | HBA: 18 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.66 | CX Basic pKa: 4.80 | CX LogP: -6.80 | CX LogD: -12.90 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.11 | Np Likeness Score: 1.31 |
1. Ciulli A, Williams G, Smith AG, Blundell TL, Abell C.. (2006) Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods., 49 (16): [PMID:16884311] [10.1021/jm060490r] |
Source(1):